Beijing Anlong Biopharmaceutical Co., Ltd.
PrivateLast Round
Series B
Extension
Jan 7, 2026
Total Funding Raised
$58.2M
Company Overview
Beijing Anlong Biopharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B Extension round in January 2026.
Beijing Anlong Biopharmaceutical Co., Ltd. is a biotechnology company that develops gene therapy products for the treatment of ophthalmological, neurological, and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Anlong Biopharmaceutical Co., Ltd. Comparables
Compare Beijing Anlong Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exegenesis Bio | 89% | |
| Frontera Therapeutics | 81% | |
| HuidaGene Therapeutics | 80% |
For institutional investors. Book with your work email.
Beijing Anlong Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2026 | ||||
| Series A Extension | Jan 23, 2024 | ||||
| Series A | Jun 9, 2021 | ||||
| VC Round | Jan 8, 2021 | ||||
| Early Funding | Jul 8, 2020 | ||||
Angel | Aug 9, 2019 |
For institutional investors. Book with your work email.
Beijing Anlong Biopharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tigeryeah Capital | Series A |
| Oceanpine Capital | Series A, VC Round |
| Anlong Fund | VC Round |
| Shanghai Honghui Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2025
Grew 1809% MoM, reaching 210 monthly visitors.
- Nov 23, 2024
Monthly visitors increased 138% MoM.
For institutional investors. Book with your work email.
Beijing Anlong Biopharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beijing Anlong Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Anlong Biopharmaceutical Co., Ltd. a public or private company?
Beijing Anlong Biopharmaceutical Co., Ltd. is a private company.
What is the current stock price of Beijing Anlong Biopharmaceutical Co., Ltd.?
Beijing Anlong Biopharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Anlong Biopharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beijing Anlong Biopharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Beijing Anlong Biopharmaceutical Co., Ltd. is not publicly available.
Can I buy Beijing Anlong Biopharmaceutical Co., Ltd. stock?
Beijing Anlong Biopharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beijing Anlong Biopharmaceutical Co., Ltd.'s last funding round?
Beijing Anlong Biopharmaceutical Co., Ltd.'s most recent funding round was Series B Extension on January 7, 2026.
Who are the main investors in Beijing Anlong Biopharmaceutical Co., Ltd.?
Key investors in Beijing Anlong Biopharmaceutical Co., Ltd. include Tigeryeah Capital, Oceanpine Capital, Anlong Fund, Shanghai Honghui Asset Management.
Will Beijing Anlong Biopharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Anlong Biopharmaceutical Co., Ltd..
How can I track Beijing Anlong Biopharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Beijing Anlong Biopharmaceutical Co., Ltd.'s shares on secondary markets.